Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
15M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
2.84M
-
Shares change
-
+67.3K
-
Total reported value, excl. options
-
$13.2M
-
Value change
-
+$373K
-
Number of buys
-
11
-
Number of sells
-
-11
-
Price
-
$4.67
Significant Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q4 2021
28 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q4 2021.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.84M shares
of 15M outstanding shares and own 18.94% of the company stock.
Largest 10 shareholders include DIMENSIONAL FUND ADVISORS LP (653K shares), RENAISSANCE TECHNOLOGIES LLC (607K shares), VANGUARD GROUP INC (391K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (236K shares), BERKSHIRE ASSET MANAGEMENT LLC/PA (182K shares), ACADIAN ASSET MANAGEMENT LLC (147K shares), BlackRock Inc. (138K shares), TWO SIGMA INVESTMENTS, LP (82.9K shares), MARSHALL WACE, LLP (79.8K shares), and STATE STREET CORP (65.8K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.